Welcome to our dedicated page for Nanophase Tech news (Ticker: NANX), a resource for investors and traders seeking the latest updates and insights on Nanophase Tech stock.
Solésence, Inc. (OTCQB: NANX), formerly Nanophase Technologies Corporation, generates frequent news related to mineral-based skin health technologies, beauty science, and corporate developments. Company announcements describe Solésence as a leader in scientifically driven health care solutions across beauty and life science categories, with a focus on mineral-based sun and environmental protection and skin health.
News items for NANX often cover financial results, including quarterly and full-year earnings releases that discuss revenue trends, profitability, and operational highlights. These releases may describe record revenue periods, changes in product mix, and investments in operations, research and development, and team expansion to support growth. They also provide details on production capabilities, such as expanded batch-making capacity and added clean room space for filling and assembly of products.
Corporate strategy and branding are another recurring theme. The company has announced its rebranding from Nanophase Technologies Corporation to Solésence, Inc., highlighting the success of its beauty science platform and its commitment to innovation, self-expression, and inclusivity in skin health. News coverage also includes information about Solésence Beauty Science winning industry awards for mineral-based formulations and participating in events such as the Chicago Innovation Awards and related recognition activities.
Investors following NANX news will also find updates on capital markets activity, including the company’s announcement that it received approval to transfer its listing to the Nasdaq Capital Market, where it will trade under the ticker symbol SLSN. In addition, the company regularly announces conference calls and webcasts to discuss financial results and provide business updates. For those tracking Solésence, the NANX news feed offers a centralized view of financial performance, operational progress, branding milestones, and capital markets developments.
Solésence Beauty Science has received TGA GMP site clearance, allowing Nanophase Technologies (NANX), its wholly owned subsidiary, to manufacture and market sunscreens in Australia. This long-awaited approval, anticipated for years, enables expansion into a sun care market valued at approximately $120 million USD. CEO Jess Jankowski emphasized the potential for growth in Australia, while COO Kevin Cureton noted an exciting opportunity for globalization and collaboration with brand partners. The approval is a significant milestone for Solésence, enhancing its product offerings in environmental protection technologies.
Nanophase Technologies (OTCQB: NANX) reported a record third quarter with an impressive 80% year-over-year growth. For the nine months ending September 30, 2021, revenue reached $22.1 million, exceeding the full year 2020 revenue by 98%. The Solésence product line saw a remarkable growth of 204% to $13.4 million. Income from operations increased to $2.9 million, with a net income of $2.7 million, or $0.04 per share. The company anticipates continued growth through 2022, bolstered by existing purchase orders worth $27 million.
Nanophase Technologies Corporation (OTCQB: NANX) will release its third quarter 2021 financial results on November 3, 2021, at 3:00 p.m. CDT. This will be followed by a conference call on November 4, 2021, at 10:00 a.m. CDT, hosted by CEO Jess Jankowski and COO Kevin Cureton. U.S. callers can dial 877-312-8776, while international callers can reach 408-774-4007, using conference ID 6190086. The call can also be accessed via www.nanophase.com under Investor Relations.
Nanophase Technologies Corporation (NANX) reported significant growth, achieving 69% year-over-year revenue increase in the six months ending June 30, 2021, totaling $14.2 million compared to $8.4 million in 2020. The company saw triple-digit growth in its Solésence beauty science segment, with revenues hitting $8.8 million, marking a 210% increase. Personal care ingredient revenues were $3.2 million, down 8% year-over-year. Despite a strong first half, demand for medical diagnostics appears to be declining. A net income of $1.4 million was reported, up from $0.4 million in 2020.
Nanophase Technologies Corporation (NANX) announced a remarkable 75% year-over-year growth with $7.1 million in revenue for Q1 2021, up from $4.0 million in 2020. Solésence beauty science sales surged 182% to $4.3 million, making up over 60% of 2020's total revenue. Additionally, advanced materials revenue rose 133% to $1.4 million, driven by medical diagnostics. However, personal care ingredients revenue fell 28%. The company secured over $14 million in purchase orders for Q2 and Q3, indicating strong future demand.
Nanophase Technologies Corporation (OTCQB: NANX) reported a remarkable 35% growth in 2020, achieving a net income of $1 million, or $0.03 per share, compared to a net loss of $3 million in 2019. Notable revenue increases were observed in Solésence products, which rose 263% to $6.7 million, and advanced materials, up 77% to $4.9 million, driven largely by medical diagnostics. The company anticipates continued market acceptance, with $12 million in purchase orders entering 2021. Despite a 30% decline in personal care ingredient sales, overall demand for their innovative products has increased significantly.